Massachusett's General — Boston, Massachusetts

Massachusett's General is a clinical research site located in Boston, Massachusetts, United States 02114.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Massachusett's General has participated in 1 clinical trials.

Therapeutic areas: Bladder Cancer, Urothelial Carcinoma.

Sponsors: ALX Oncology Inc..

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Massachusett's General?

Massachusett's General has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Massachusett's General conducted?

Massachusett's General has 1 clinical trials on record. Their work covers Bladder Cancer, Urothelial Carcinoma.

Is Massachusett's General accredited by Crixeo Health?

Massachusett's General has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Massachusett's General?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.